228 related articles for article (PubMed ID: 9469303)
21. H-ras oncogene mutation in dedifferentiated chondrosarcoma: polymerase chain reaction-restriction fragment length polymorphism analysis.
Sakamoto A; Oda Y; Adachi T; Oshiro Y; Tamiya S; Tanaka K; Matsuda S; Iwamoto Y; Tsuneyoshi M
Mod Pathol; 2001 Apr; 14(4):343-9. PubMed ID: 11301351
[TBL] [Abstract][Full Text] [Related]
22. Tissue inhibitor of metalloproteinase 1 is an independent predictor of prognosis in patients with nonsmall cell lung carcinoma who undergo resection with curative intent.
Gouyer V; Conti M; Devos P; Zerimech F; Copin MC; Créme E; Wurtz A; Porte H; Huet G
Cancer; 2005 Apr; 103(8):1676-84. PubMed ID: 15754326
[TBL] [Abstract][Full Text] [Related]
23. Treatment with low-dose interferon-alpha restores the balance between matrix metalloproteinase-9 and E-cadherin expression in human transitional cell carcinoma of the bladder.
Slaton JW; Karashima T; Perrotte P; Inoue K; Kim SJ; Izawa J; Kedar D; McConkey DJ; Millikan R; Sweeney P; Yoshikawa C; Shuin T; Dinney CP
Clin Cancer Res; 2001 Sep; 7(9):2840-53. PubMed ID: 11555602
[TBL] [Abstract][Full Text] [Related]
24. Molecular profiling of human chondrosarcomas for matrix production and cancer markers.
Söderström M; Böhling T; Ekfors T; Nelimarkka L; Aro HT; Vuorio E
Int J Cancer; 2002 Jul; 100(2):144-51. PubMed ID: 12115562
[TBL] [Abstract][Full Text] [Related]
25. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
26. Gamma Knife surgery for intracranial chordoma and chondrosarcoma: radiosurgical perspectives and treatment outcomes.
Kim JH; Jung HH; Chang JH; Chang JW; Park YG; Chang WS
J Neurosurg; 2014 Dec; 121 Suppl():188-97. PubMed ID: 25434952
[TBL] [Abstract][Full Text] [Related]
27. Chondrosarcoma of bone: a statistical analysis of prognostic factors.
Wang JW; Ger LP; Shih CH; Hsieh MC
J Formos Med Assoc; 1991 Oct; 90(10):998-1003. PubMed ID: 1685183
[TBL] [Abstract][Full Text] [Related]
28. Association of trypsin expression with tumour progression and matrilysin expression in human colorectal cancer.
Yamamoto H; Iku S; Adachi Y; Imsumran A; Taniguchi H; Nosho K; Min Y; Horiuchi S; Yoshida M; Itoh F; Imai K
J Pathol; 2003 Feb; 199(2):176-84. PubMed ID: 12533830
[TBL] [Abstract][Full Text] [Related]
29. Increased expression of matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 is correlated with poor prognostic variables in patients with thymic epithelial tumors.
Sogawa K; Kondo K; Fujino H; Takahashi Y; Miyoshi T; Sakiyama S; Mukai K; Monden Y
Cancer; 2003 Nov; 98(9):1822-9. PubMed ID: 14584061
[TBL] [Abstract][Full Text] [Related]
30. Immunohistochemical detection of matrix metalloproteinases (MMP) 1 and 2, and tissue inhibitor of metalloproteinase 2 (TIMP 2) in stage I and II endometrial cancer.
Moser PL; Hefler L; Tempfer C; Neunteufel W; Kieback DG; Gitsch G
Anticancer Res; 1999; 19(3B):2365-7. PubMed ID: 10472357
[TBL] [Abstract][Full Text] [Related]
31. Nitric oxide synthases, cyclooxygenase-2, nitrotyrosine, and angiogenesis in chondrosarcoma and their relation to prognosis.
Nakagawa SA; Lopes A; Lopes de Carvalho A; Rossi BM; Werneck da Cunha I; Soares FA; Chung WT; Alves LA
J Bone Joint Surg Am; 2010 Jul; 92(8):1738-46. PubMed ID: 20660237
[TBL] [Abstract][Full Text] [Related]
32. Inhibitory effects of a benz[f]indole-4,9-dione analog on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
Park HJ; Lee HJ; Min HY; Chung HJ; Suh ME; Park-Choo HY; Kim C; Kim HJ; Seo EK; Lee SK
Eur J Pharmacol; 2005 Dec; 527(1-3):31-6. PubMed ID: 16309669
[TBL] [Abstract][Full Text] [Related]
33. Prognosis of Primary and Recurrent Chondrosarcoma of the Rib.
Roos E; van Coevorden F; Verhoef C; Wouters MW; Kroon HM; Hogendoorn PC; van Houdt WJ
Ann Surg Oncol; 2016 Mar; 23(3):811-7. PubMed ID: 26498768
[TBL] [Abstract][Full Text] [Related]
34. Immunohistochemical analysis of matrix metalloproteinase-1, -3, and -13 in naturally occurring cartilaginous tumors of dogs.
Kuroki K; Kreeger JM; Cook JL; Tomlinson JL; Johnson GC; Pace LW; Turnquist SE; Turk JR; Ramos JA; Miller MA
Am J Vet Res; 2002 Sep; 63(9):1285-91. PubMed ID: 12224862
[TBL] [Abstract][Full Text] [Related]
35. [Relationship of expression unbalance of matrix metalloproteinase and tissue inhibitor of metalloproteinase to invasiveness and metastasis in gastric carcinomas].
Li L; Zhang S; Lin H; Lin JY
Ai Zheng; 2002 Mar; 21(3):305-10. PubMed ID: 12452001
[TBL] [Abstract][Full Text] [Related]
36. Prognostic significance of stromelysin-3 and tissue inhibitor of matrix metalloproteinase-2 in esophageal cancer.
Sharma R; Chattopadhyay TK; Mathur M; Ralhan R
Oncology; 2004; 67(3-4):300-9. PubMed ID: 15557792
[TBL] [Abstract][Full Text] [Related]
37. Prognostic values of matrix metalloproteinase family expression in human colorectal carcinoma.
Asano T; Tada M; Cheng S; Takemoto N; Kuramae T; Abe M; Takahashi O; Miyamoto M; Hamada J; Moriuchi T; Kondo S
J Surg Res; 2008 May; 146(1):32-42. PubMed ID: 17543340
[TBL] [Abstract][Full Text] [Related]
38. Prognostic relevance of TGF-beta1 and PAI-1 in cervical cancer.
Hazelbag S; Kenter GG; Gorter A; Fleuren GJ
Int J Cancer; 2004 Dec; 112(6):1020-8. PubMed ID: 15386352
[TBL] [Abstract][Full Text] [Related]
39. Matrix metalloproteinase 9 (gelatinase B) is expressed in multinucleated giant cells of human giant cell tumor of bone and is associated with vascular invasion.
Ueda Y; Imai K; Tsuchiya H; Fujimoto N; Nakanishi I; Katsuda S; Seiki M; Okada Y
Am J Pathol; 1996 Feb; 148(2):611-22. PubMed ID: 8579123
[TBL] [Abstract][Full Text] [Related]
40. Expression of MMP-9 decreases metastatic potential of Chondrosarcoma: an immunohistochemical study.
Malcherczyk D; Heyse TJ; El-Zayat BF; Kunzke V; Moll R; Fuchs-Winkelmann S; Paletta JRJ
BMC Musculoskelet Disord; 2018 Jan; 19(1):9. PubMed ID: 29316907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
